The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-00536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Negotiation of long term lease and development agreement for an international hotel company
Represented an international hotel company in the negotiation of long term lease of condominium unit in multi-use high rise building on historic more
Technology license for a networking equipment company
Represented networking equipment company in technology license. more
First lien and second lien credit facilities of a paper manufacturing company
Representation of lead agent and lender in connection with $95M syndicated secured first lien and second lien credit facilities used to finance the more
Cavalier v. Jim Henson Co., Inc.
Won summary adjudication on behalf of defendants The Jim Henson Company, Simon & Schuster, Inc. and Viacom Inc. in an idea submission case on the more